Serelora Acquires ACTIN Care Groups' Risk-Stratification Software

Serelora, Inc., a company building an agentic electronic health record (EHR), today announced it has acquired the clinical risk-stratification software of ACTIN Care Groups. The acquisition extends Serelora's AI-native EHR beyond individual patient documentation into population-level analysis, giving clinicians and health systems the ability to identify, stratify, and act on patient risk across entire populations.

The acquired technology includes WellCheck, a 27-instrument preventive risk battery developed by ACTIN Care Groups to systematically assess patients across clinical, behavioral, and social risk factors. Within Serelora, these validated instruments become a native capability of the record itself, meaning risk scores can be generated, surfaced, and acted upon inside the same agentic system clinicians already use to document care.

Traditional EHRs were built to capture one encounter at a time. As an agentic EHR, Serelora is designed to do more than store what happened, reasoning over the record and taking work off clinicians' plates. Adding risk stratification extends that intelligence from the individual chart to the whole population, allowing an organization to see not just who is sick today, but who is trending toward risk tomorrow.

"An EHR shouldn't just record what already happened to a patient, it should help clinicians see what's coming next, whether that's for one patient or an entire population," said Spencer Wozniak, chief technology officer and co-founder of Serelora. "ACTIN built one of the most disciplined risk-stratification engines in preventive care. Bringing it into our agentic EHR means risk isn't a report someone runs later, it's part of the record itself, ready to drive action. This is the natural next step in what an EHR can be."

The expanded platform positions Serelora to support the independent practices, health systems, and risk-bearing organizations navigating the shift to value-based care, where success increasingly depends on identifying rising-risk patients early and intervening before complications and costs escalate. By embedding population-level analysis directly in the record, Serelora aims to close the gap between knowing a patient is at risk and doing something about it.

The risk-stratification capabilities will be integrated into the Serelora platform and rolled out to customers in phases. Financial terms of the transaction were not disclosed.